Psychiatry and Neurology, Neurology · Kansas City, MO
NPI
1245278712
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4400 Broadway, Suite 520
Kansas City, MO, 64111
Phone (816) 531-4080
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
646 services
Medicare patients, 2024
309
Average age 75
Drug cost, 2024
$3.9M
2,924 prescriptions
Company payments, 2025
$114
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Schwartzman was code 95886 (electrical nerve conductivity), 188 times for 105 patients. In total Michael J Schwartzman billed 646 services in 20 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-11-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 188 | 105 | $69.80 | $13K |
| 99214 Office E&M - Established | Office | 112 | 81 | $86.42 | $9,679 |
| 99213 Office E&M - Established | Office | 72 | 62 | $60.96 | $4,389 |
| 99204 Office E&M - New | Office | 65 | 65 | $112.81 | $7,332 |
| 99215 Office E&M - Established | Office | 50 | 47 | $122.97 | $6,149 |
| 95911 Electrical Nerve Conductivity | Office | 40 | 40 | $136.27 | $5,451 |
| 95910 Electrical Nerve Conductivity | Office | 37 | 37 | $112.32 | $4,156 |
| 95909 Electrical Nerve Conductivity | Office | 34 | 33 | $89.45 | $3,041 |
By year: 2022 $57K for 638 services; 2023 $56K for 653 services; 2024 $57K for 646 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Schwartzman prescribed most often to Medicare patients was Gabapentin, with 330 prescriptions and refills. In total Michael J Schwartzman wrote 2,924 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 330 | 532 | 81 | $6,568 |
| Pyridostigmine Bromide Generic | 178 | 347 | 43 | $16K |
| Primidone Generic | 165 | 322 | 36 | $5,190 |
| Pregabalin Generic | 164 | 257 | 39 | $5,493 |
| Prednisone Generic | 152 | 239 | 30 | $963 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 131 | 202 | 24 | $2,505 |
| Duloxetine Hcl Generic | 123 | 234 | 31 | $2,818 |
| Topiramate Generic | 95 | 149 | 22 | $891 |
| Donepezil Hcl Generic | 93 | 168 | 24 | $495 |
| Ropinirole Hcl Generic | 72 | 139 | 17 | $833 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 66 | 66 | Under 11 | $321K |
| Levetiracetam Generic | 64 | 107 | 15 | $1,482 |
| Mycophenolate Mofetil Generic | 63 | 89 | Under 11 | $6,473 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 61 | 61 | Under 11 | $846K |
| Baclofen Generic | 58 | 78 | 12 | $1,361 |
Brand drugs: 355 claims; generic drugs: 2,569 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael J Schwartzman $114 ($114 in general payments such as food, travel and fees) from 2 companies. The largest payer was Janssen Biotech, Inc. with $99.99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.